Skip to content

Infant Formula Supplemented With Probiotic Microorganisms and/or Prebiotic.

Evaluation of the Effect of Milk Based Infant Formula Supplemented Either With Probiotic Microorganisms and/or With Prebiotic on the Intestinal Microflora During the First 4 Months of Life of Healthy, Full Term Infants and it's Long Term Effect on Morbidity up to the Age of 9 Months

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00836771
Enrollment
270
Registered
2009-02-04
Start date
2009-07-31
Completion date
2014-12-31
Last updated
2013-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Focus on Healthy Infant Growth.

Keywords

Infant formula, Probiotic microorganisms, prebiotic

Brief summary

Evaluation the nutritional suitability of a based milk infant formula supplemented with friendly bacteria (probiotic microorganisms) and or nutritional fibers (prebiotic) to healthy, full term infants compare with an otherwise identical widely used commercially available milk based infant formula and/or breast feed

Interventions

DIETARY_SUPPLEMENTInfant Formula

Sponsors

Materna Laboratories
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Days to 21 Days
Healthy volunteers
Yes

Inclusion criteria

* Healthy term infants of both sexes, born in natural labor . * Single birth. * Full term infants (born between the 37th and 42nd week of gestation) * Infants with birth weight \>2500 g. * Recruitment age will be 0-21 days. * Infants whose mothers are unable to breast feed or have chosen not to breast feed prior to the study enrollment. * Infants whose parents have agreed to participate in the study up to the age of 9 months.. * Infants whose parents have agreed to remain exclusively on the same product for 16 weeks of age.. * Infants whose parents have signed the informed consent form. * Infants whose parents are able to understand the protocol requirements and to fill out the infant's diary and agree to completely fill out the parents' questionnaires during the period Of 9 months

Exclusion criteria

* Twins. * Premature or low birth weight (\< 2500 g). * Chromosomal abnormalities or congenital malformation. * Suffering jaundice which require phototherapy. * Proven or suspected family history of allergy to cow's milk. * Having been treated with antibiotics or other drugs during the last three days or more prior to the commencement of the study.

Design outcomes

Primary

MeasureTime frame
weight gain1 to 120 days of age

Secondary

MeasureTime frame
Anthropometric1-120 days of age
GI tolerance1-120 days of age

Other

MeasureTime frameDescription
Influence on the microbial content of the stool3 - 4 times: 1-16 d, 4 w 16 w and 36 wStool were collected to analyze the microbial content of certain bacteria upon enrollment and at the age of 4, 16. and 36 w Stool were collected and delivery to the lab in coolers within 12 h

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026